Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_assertion description "[Because RALBP1 transports anthracycline and Vinca alkaloid drugs, as well as GS-E, and because it confers resistance to these drugs, we proposed that depletion or inhibition of RALBP1 should cause regression of human solid tumors that overexpress RALBP1 and augment chemotherapy efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_assertion evidence source_evidence_literature NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_assertion SIO_000772 17483352 NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_assertion wasDerivedFrom befree-20140225 NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_assertion wasGeneratedBy ECO_0000203 NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP602092.RAGlBgW0mcSv2ZlaNQnCgFPuna7tf57EkvdGTlJt9qoIc130_provenance.